Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$131.85

-0.75 (-0.57%)

15:13
07/17/17
07/17
15:13
07/17/17
15:13

Technical Earnings Preview: Johnson & Johnson trending down ahead of news

The shares have been in a minor downtrend since hitting a peak of price in late June. If the news or outlook are a negative disappointment, next support of note would be at the $130 area. A breakdown below $130 would confirm a larger topping process underway. Next supports below would be at $128.25, $127.51, the $125 area, and $122.50. If the news is instead a positive surprise, a breakout above the $133 area would break the downtrend. Next resistance levels to watch as potential upside objectives would be at $135.01 and the 52-week high at $137. A move above $137 would open up a run to the $140 area.

  • 18

    Jul

  • 09

    Aug

JNJ Johnson & Johnson
$131.85

-0.75 (-0.57%)

06/14/17
RHCO
06/14/17
NO CHANGE
RHCO
Eli Lilly has positive read through from J&J data, says SunTrust
SunTrust analyst John Boris says that data for Johnson & Johnson's (JNJ) Invokana for diabetes represented a best-case scenario for Eli Lilly (LLY). J&J's drug "significantly reduced the combined risk of cardiovascular death, myocardial infarction and nonfatal stroke in diabetes patients at risk for or with a history of CV diseases," and its efficacy on CV death is positive for the SGLT-2 class, to which Eli Lilly's Jardiance also belongs, according to the analyst. But the data leaves Jardiance, which reduced CV death by a statistically significant 38% versus Invokana's non-significant 13%, as the best in the class, wrote the analyst, who reiterates a $101 price target and a Buy rating on Eli Lilly.
06/20/17
ADAM
06/20/17
NO CHANGE
Target $10
ADAM
Buy
Novadaq competing bids possible if not probable, says Canaccord
Canaccord analyst Jason Mills noted Novadaq (NVDQ) received an acquisition offer from Stryker (SYK) at a much greater equity value than what the company was trading at prior to the bid. Although he thinks Stryker is the most logical buyer of the franchise, he thinks there are several other potential acquirers, including Medtronic (MDT), Johnson & Johnson (JNJ) and Intuitive Surgical (ISRG), in that order. Mills believes this is a good exit for the company and that Stryker is getting a good asset. Mills maintains his Buy rating and $10 price target on Novadaq shares.
06/27/17
06/27/17
NO CHANGE

Large cap pharma could benefit from upcoming executive order, says Wells Fargo
Wells Fargo says that, based on press reports, large cap pharma could benefit from President Trump's upcoming executive order on drug pricing. The firm says the articles indicate that the order will not create major reforms or do anything to lower consumers' costs or solve current pricing issues. Publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
07/14/17
WELS
07/14/17
NO CHANGE
WELS
Underperform
J&J approval another negative for Valeant, says Wells Fargo
Wells Fargo analyst David Maris says Valeant Pharmaceuticals (VRX) has a new competitor in the psoriasis space after the FDA yesterday approved Tremfya from Johnson & Johnson (JNJ). The news is another negative for Valeant, which is about to launch its own psoriasis treatment, Siliq, in the second half of 2017, Maris tells investors in a research note. With Talz from Eli Lilly (LLY), Humira from AbbVie (ABBV), Cosentyx from Novartis (NVS) and now J&J as a new competitor, Valeant is unlikely to be competitive in the psoriasis market, Maris contends. He believes his peak sales estimate of $250M for Siliq may prove optimistic given the competition. Maris an Underperform rating on Valeant with a $9 price target. The drugmaker closed yesterday at $17.29.

TODAY'S FREE FLY STORIES

T

AT&T

$33.98

0.07 (0.21%)

, ATUS

Altice USA

$18.69

0.07 (0.38%)

12:36
09/25/18
09/25
12:36
09/25/18
12:36
Hot Stocks
AT&T launches new advertising company called Xandr »

AT&T (T) announced…

T

AT&T

$33.98

0.07 (0.21%)

ATUS

Altice USA

$18.69

0.07 (0.38%)

FTR

Frontier Communications

$6.49

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 21

    Oct

  • 24

    Oct

  • 06

    Nov

  • 12

    Nov

SQ

Square

$92.04

5.975 (6.94%)

12:34
09/25/18
09/25
12:34
09/25/18
12:34
Hot Stocks
Square introduces new payroll app for employers »

Square said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 26

    Nov

ULTA

Ulta Beauty

$277.98

-3.03 (-1.08%)

12:32
09/25/18
09/25
12:32
09/25/18
12:32
Conference/Events
Cowen retail/luxury analyst to hold an analyst/industry conference call »

Retail/Luxury Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

ILIAF

Iliad

$0.00

(0.00%)

12:30
09/25/18
09/25
12:30
09/25/18
12:30
Downgrade
Iliad rating change  »

Iliad downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXP

Eagle Materials

$86.54

0.08 (0.09%)

12:27
09/25/18
09/25
12:27
09/25/18
12:27
Periodicals
Breaking Periodicals news story on Eagle Materials »

Hedgeye adds Eagle…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 06

    Nov

EA

Electronic Arts

$115.78

0.52 (0.45%)

, MSFT

Microsoft

$114.29

-0.43 (-0.37%)

12:26
09/25/18
09/25
12:26
09/25/18
12:26
Hot Stocks
Game On: Sony launching PlayStation Classic in December »

Welcome to "Game…

EA

Electronic Arts

$115.78

0.52 (0.45%)

MSFT

Microsoft

$114.29

-0.43 (-0.37%)

SNE

Sony

$58.61

1.75 (3.08%)

NTDOY

Nintendo

$0.00

(0.00%)

SGAMY

Sega Sammy Holdings

$0.00

(0.00%)

CCOEY

Capcom

$0.00

(0.00%)

UBSFY

Ubisoft

$0.00

(0.00%)

TTWO

Take-Two

$135.22

0.35 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 13

    Nov

  • 28

    Nov

  • 03

    Mar

DDD

3D Systems

$20.19

1 (5.21%)

12:25
09/25/18
09/25
12:25
09/25/18
12:25
Options
3D Systems call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

MDWD

MediWound

$6.45

(0.00%)

12:23
09/25/18
09/25
12:23
09/25/18
12:23
Recommendations
MediWound analyst commentary  »

MediWound BARDA contract…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

KORS

Michael Kors

$67.12

0.41 (0.61%)

, SONC

Sonic

$43.31

6.7 (18.30%)

12:22
09/25/18
09/25
12:22
09/25/18
12:22
General news
Fly Intel: Wall Street's top stories at midday »

Stocks opened in positive…

KORS

Michael Kors

$67.12

0.41 (0.61%)

SONC

Sonic

$43.31

6.7 (18.30%)

BMWYY

BMW

$0.00

(0.00%)

F

Ford

$9.49

-0.1 (-1.04%)

GM

General Motors

$34.00

-0.74 (-2.13%)

FCAU

Fiat Chrysler

$18.10

-0.21 (-1.15%)

XOXO

XO Group

$34.75

7.13 (25.81%)

ASNA

Ascena Retail

$4.46

0.44 (10.95%)

TGTX

TG Therapeutics

$5.98

-3.275 (-35.41%)

CTL

CenturyLink

$21.13

-1.77 (-7.73%)

TMUS

T-Mobile

$69.28

0.35 (0.51%)

S

Sprint

$6.42

0.03 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 01

    Oct

  • 02

    Oct

  • 04

    Oct

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
09/25/18
09/25
12:17
09/25/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
09/25/18
09/25
12:16
09/25/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
09/25/18
09/25
12:15
09/25/18
12:15
General news
Treasury Option Action: another round of put buying »

Treasury Option Action:…

THR

Thermon Group

$26.12

0.14 (0.54%)

12:15
09/25/18
09/25
12:15
09/25/18
12:15
Conference/Events
Thermon Group management to meet with William Blair »

Group luncheon with CFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

12:10
09/25/18
09/25
12:10
09/25/18
12:10
General news
Treasury 5-year auction outlook: the $38 B 5-year sale may not do much better »

Treasury 5-year auction…

I

Intelsat

$26.03

3.32 (14.62%)

12:05
09/25/18
09/25
12:05
09/25/18
12:05
Options
Intelsat call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$11.45

-0.295 (-2.51%)

, EXC

Exelon

$42.67

-0.54 (-1.25%)

12:04
09/25/18
09/25
12:04
09/25/18
12:04
Periodicals
GE turbine at EDF's Bouchain plant halted following U.S. shutdowns, Reuters says »

A General Electric (GE)…

GE

General Electric

$11.45

-0.295 (-2.51%)

EXC

Exelon

$42.67

-0.54 (-1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 11

    Nov

SAN

Banco Santander

$5.29

0.015 (0.28%)

, UBS

UBS

$16.47

0.075 (0.46%)

12:03
09/25/18
09/25
12:03
09/25/18
12:03
Hot Stocks
Banco Santander appoints Andrea Orcel as new CEO »

Banco Santander (SAN)…

SAN

Banco Santander

$5.29

0.015 (0.28%)

UBS

UBS

$16.47

0.075 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ORCL

Oracle

$51.82

0.57 (1.11%)

11:57
09/25/18
09/25
11:57
09/25/18
11:57
Hot Stocks
S&P revises Oracle outlook to Negative on higher share repurchases »

S&P Global Ratings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

11:55
09/25/18
09/25
11:55
09/25/18
11:55
General news
Treasury's $17 B 2-year FRN reopening was awarded at a high discount margin of 0.050% »

Treasury's $17 B…

11:55
09/25/18
09/25
11:55
09/25/18
11:55
Conference/Events
Stephens retail/broadlines analyst to hold a luncheon meeting »

Specialty Pharmaceuticals…

11:55
09/25/18
09/25
11:55
09/25/18
11:55
Conference/Events
Stephens real estate services analyst to hold group luncheon »

Real Estate Services…

11:55
09/25/18
09/25
11:55
09/25/18
11:55
Conference/Events
RBC Capital internet analyst to hold a luncheon »

Internet Analyst Mahaney…

SAGE

Sage Therapeutics

$140.90

-1.71 (-1.20%)

11:53
09/25/18
09/25
11:53
09/25/18
11:53
Hot Stocks
Sage depression drug to get FDA panel review on Nov. 2 »

The FDA earlier today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

DNKN

Dunkin' Brands

$73.41

0.53 (0.73%)

11:52
09/25/18
09/25
11:52
09/25/18
11:52
Hot Stocks
Dunkin' Brands to officially rebrands 'Dunkin Donuts' as just 'Dunkin' »

Dunkin' Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$150.89

-0.67 (-0.44%)

11:51
09/25/18
09/25
11:51
09/25/18
11:51
Conference/Events
Deere management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.